ClearPoint Neuro (CLPT) Cash & Current Investments (2011 - 2026)
ClearPoint Neuro (CLPT) posted Cash & Current Investments of $35.6 million for Q1 2026, down 22.49% sequentially from $45.9 million in Q4 2025, and up 187.34% YoY from $12.4 million in Q1 2025.
ClearPoint Neuro (CLPT) Cash & Current Investments (2011 - 2026) Analysis & Trends
ClearPoint Neuro has reported Cash & Current Investments for 16 years, with the latest figure at $35.6 million in Q1 2026.
- Quarterly Cash & Current Investments rose 187.34% year-over-year to $35.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.6 million (up 187.34% YoY) and the FY2025 annual result came in at $45.9 million, up 128.47% from the prior year.
- Cash & Current Investments retreated to $35.6 million in Q1 2026 per CLPT's latest filing, from $45.9 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $49.7 million in Q1 2022 and troughed at $12.4 million in Q1 2025.
- A 5-year average of $33.0 million and a median of $35.4 million in 2024 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2025 and 2026: Cash & Current Investments tumbled 64.96% in 2025, then jumped 187.34% in 2026.
- Over 5 years, Cash & Current Investments stood at $37.5 million in 2022, then tumbled by 38.42% to $23.1 million in 2023, then slipped by 12.99% to $20.1 million in 2024, then soared by 128.47% to $45.9 million in 2025, then retreated by 22.49% to $35.6 million in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $35.6 million, $45.9 million, and $38.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 482.30 Mn |
| 10 | ClearPoint Neuro | 466.38 Mn | 436.98 Mn | 6.71 Mn | 29.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.40 Mn |
| Mar 31, 2026 | 35.59 Mn |
| Dec 31, 2025 | 45.92 Mn |
| Sep 30, 2025 | 38.20 Mn |
| Jun 30, 2025 | 41.50 Mn |
| Mar 31, 2025 | 12.39 Mn |
| Dec 31, 2024 | 20.10 Mn |
| Sep 30, 2024 | 21.57 Mn |
| Jun 30, 2024 | 32.85 Mn |
| Mar 31, 2024 | 35.35 Mn |
| Dec 31, 2023 | 23.10 Mn |
| Sep 30, 2023 | 24.34 Mn |
| Jun 30, 2023 | 26.50 Mn |
| Mar 31, 2023 | 31.69 Mn |
| Dec 31, 2022 | 37.52 Mn |
| Sep 30, 2022 | 40.46 Mn |
| Jun 30, 2022 | 45.10 Mn |
| Mar 31, 2022 | 49.66 Mn |
| Dec 31, 2021 | 54.10 Mn |
| Sep 30, 2021 | 57.65 Mn |